Leap Therapeutics, Inc.
LPTX$74M
Micro CapNASDAQPharmaceutical Preparations🇺🇸North AmericaCAMBRIDGE
Drugs in Pipeline
2
Phase 3 Programs
0
Upcoming Catalysts
0
Next Catalyst
None scheduled
Market Overview
Stock performance and key metrics
LPTX News
Catalyst Timeline
0 upcoming, 0 past
No catalysts found.
Drug Pipeline
| Drug Name | Phase | Indication | Designations | Patent |
|---|---|---|---|---|
DKN-01 | Phase 2 | Colorectal Cancer | - | - |
Paclitaxel | Phase 2 | Endometrial Cancer | - | - |
Regulatory Approvals
Data is aggregated from public sources (FDA, SEC, ClinicalTrials.gov). While we strive for accuracy, information may be incomplete, delayed, or contain errors. Terms apply